● Recruiting

A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

Condition: Advanced Cancer · Metastatic Cancer · Solid Tumor · Sponsor: Jazz Pharmaceuticals

PhasePhase 1

Planned participants332

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This phase 1 study will investigate the safety, dosing, and initial antitumor activity of JZP815 in participants with advanced or metastatic solid tumors harboring alterations in the MAPK pathway.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Trial Disclosure & Transparency · 215-832-3750 · ClinicalTrialDisclosure@JazzPharma.com

Always discuss trial participation with your own doctor first.

Locations (15)

Valkyrie Clinical Trials	Los Angeles, California, United States	Recruiting
SCRI HealthOne	Denver, Colorado, United States	Recruiting
Florida Cancer Specialists - Lake Nona	Orlando, Florida, United States	Recruiting
Florida Cancer Specialists - Sarasota	Sarasota, Florida, United States	Recruiting
University of Chicago	Chicago, Illinois, United States	Recruiting
NYU Langone Health	New York, New York, United States	Recruiting
Icahn School of Medicine at Mount Sinai	New York, New York, United States	Recruiting
Oklahoma University	Oklahoma City, Oklahoma, United States	Recruiting
University of Pennsylvania	Philadelphia, Pennsylvania, United States	Recruiting
Sidney Kimmel Cancer Center	Philadelphia, Pennsylvania, United States	Recruiting
Tennessee Oncology - Nashville	Nashville, Tennessee, United States	Recruiting
Texas Oncology- Central South	Austin, Texas, United States	Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05557045